FDA Opens Door to Quicker Approval of Osteoporosis Drugs

(MedPage Today) — The FDA has given the green light to use hip total bone mineral density (BMD) as a validated surrogate endpoint for clinical trials of osteoporosis drugs, the FDA announced Friday. A BMD test measures calcium and other bone minerals…